The EU has concluded a deal with BioNTech/Pfizer for up to 1.8 billion extra doses of its COVID-19 vaccine, European Commission chief Ursula von der Leyen said on Saturday.
The EU has concluded a deal with BioNTech/Pfizer for up to 1.8 billion extra doses of its COVID-19 vaccine, European Commission chief Ursula von der Leyen said on Saturday.
